Back to NRIX
MORGAN STANLEY NRIX Position History
Nurix Therapeutics, Inc.
Quarters held
29
Latest value
$332K
Q2 2026
Peak value
$107.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.4M |
| Q3 2025 | $153K |
| Q3 2025 | $335K |
| Q3 2025 | $10 |
| Q3 2025 | $18.1M |
| Q3 2025 | $792K |
| Q3 2025 | $45K |
| Q4 2025 | $3M |
| Q4 2025 | $525K |
| Q4 2025 | $759 |
| Q4 2025 | $29 |
| Q4 2025 | $85.7M |
| Q4 2025 | $3.2M |
| Q4 2025 | $38 |
| Q4 2025 | $128K |
| Q1 2026 | $2.9M |
| Q1 2026 | $561K |
| Q1 2026 | $28 |
| Q1 2026 | $71.8M |
| Q1 2026 | $934K |
| Q1 2026 | $2K |
| Q1 2026 | $172K |
| Q2 2026 | $5.4M |
| Q2 2026 | $1.2M |
| Q2 2026 | $26 |
| Q2 2026 | $107.5M |
| Q2 2026 | $1.1M |
| Q2 2026 | $33K |
| Q2 2026 | $332K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $332K | 13.7K | — | — |
| Q2 2026 | $33K | 1.4K | — | — |
| Q2 2026 | $1.1M | 46.2K | — | — |
| Q2 2026 | $107.5M | 4.43M | — | — |
| Q2 2026 | $26 | 1 | — | — |
| Q2 2026 | $1.2M | 47.7K | — | — |
| Q2 2026 | $5.4M | 221.7K | — | — |
| Q1 2026 | $172K | 11.1K | — | — |
| Q1 2026 | $2K | 107 | — | — |
| Q1 2026 | $934K | 60.3K | — | — |
| Q1 2026 | $71.8M | 4.64M | — | — |
| Q1 2026 | $28 | 1 | — | — |
| Q1 2026 | $561K | 36.2K | — | — |
| Q1 2026 | $2.9M | 189.3K | — | — |
| Q4 2025 | $128K | 6.7K | — | — |
| Q4 2025 | $38 | 2 | — | — |
| Q4 2025 | $3.2M | 169.5K | — | — |
| Q4 2025 | $85.7M | 4.52M | — | — |
| Q4 2025 | $29 | 1 | — | — |
| Q4 2025 | $759 | 40 | — | — |
| Q4 2025 | $525K | 27.7K | — | — |
| Q4 2025 | $3M | 157.3K | — | — |
| Q3 2025 | $45K | 4.9K | — | — |
| Q3 2025 | $792K | 85.7K | — | — |
| Q3 2025 | $18.1M | 1.96M | — | — |
| Q3 2025 | $10 | 1 | — | — |
| Q3 2025 | $335K | 36.3K | — | — |
| Q3 2025 | $153K | 16.6K | — | — |
| Q3 2025 | $1.4M | 156.5K | — | — |